Skip to main content

Table 1 Demographics, clinical features, and changes in ALSFRS-R

From: How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study

Mean age (years) ± SD

49.4 ± 11.8

Limb onset

31/43 (72.1%)

Bulbar onset

12/43 (27.9%)

Mean ALSFRS-R (Pre-Televisit) ± SD

31.7 ± 6.9

Mean ALSFRS-R (Televisit) ± SD

29.9 ± 6.5

  1. ALSFRS-R Revised Amyotrophic Lateral Sclerosis Functional Rating Scale